Copyright
©2013 Baishideng Publishing Group Co.
World J Hepatol. Dec 27, 2013; 5(12): 685-691
Published online Dec 27, 2013. doi: 10.4254/wjh.v5.i12.685
Published online Dec 27, 2013. doi: 10.4254/wjh.v5.i12.685
Table 5 Risk factors associated with 30-d mortality in patients with hepatorenal syndrome
| Variable | < 30-d mortalityn (%) | ≥30-d mortalityn (%) | Crude OR(95%CI) | Adjusted OR(95%CI) | P value |
| Age, (yr) | |||||
| < 65 | 7 (43.8) | 4 (23.5) | 1 | - | |
| ≥ 65 | 9 (56.2) | 13 (76.5) | 2.53 (0.57-11.26) | ||
| Child-Pugh class | |||||
| B | 5 (31.2) | 13 (76.5) | 1 | 11.98 (0.97-148.23) | 0.053 |
| C | 11 (68.8) | 4 (23.5) | 7.15 (1.53-33.37) | ||
| Sodium | |||||
| ≥ 132 mEq/L | 3 (18.8) | 10 (58.8) | 1 | ||
| < 132 mEq/L | 13 (81.2) | 7 (41.2) | 6.19 (1.27-30.17) | 31.39 (1.54-641.83) | 0.020 |
| Total bilirubin | |||||
| ≤ 3.6 mg/dL | 4 (25.0) | 12 (70.6) | 1 | ||
| > 3.6 mg/dL | 12 (75.0) | 5 (29.4) | 7.20 (1.55-33.56) | 0.69 (0.17-28.06) | 0.800 |
| Hepatocellular carcinoma | |||||
| Absent | |||||
| Present | 13 (81.2) | 8 (47.1) | 1 | ||
| 3 (18.8) | 9 (52.9) | 4.88 (1.01-23.57) | 1.37 (0.13-14.91) | 0.700 | |
| MELD score | |||||
| ≤ 27 | 4 (25.0) | 14 (82.4) | 1 | ||
| > 27 | 12 (75.0) | 3 (17.6) | 14.0 (2.60-75.41) | 18.72 (1.63-214.56) | 0.010 |
- Citation: Licata A, Maida M, Bonaccorso A, Macaluso FS, Cappello M, Craxì A, Almasio PL. Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study. World J Hepatol 2013; 5(12): 685-691
- URL: https://www.wjgnet.com/1948-5182/full/v5/i12/685.htm
- DOI: https://dx.doi.org/10.4254/wjh.v5.i12.685